Cleveland HeartLab pulls in $15M | Wall Street Beat
Cleveland HeartLab raises nearly $15 million for its CardioMPO test for cardiac inflammation.
Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.
The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic's center for cardiovascular diagnostics and prevention.
Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.